HC Wainwright & Co. Reiterates Buy on Palisade Bio, Maintains $7 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor has reiterated a Buy rating on Palisade Bio (NASDAQ: PALI) and maintained a price target of $7 for the stock.